Pharming Group (PHGUF) Short Interest Ratio & Short Volume $1.30 +0.14 (+12.07%) As of 10:21 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Pharming Group Short Interest DataPharming Group (PHGUF) has a short interest of 4.95 million shares, representing 0.74% of the float (the number of shares available for trading by the public). This marks a 98.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 500 shares to cover all short positions.Current Short Interest4,952,300 sharesPrevious Short Interest2,494,900 sharesChange Vs. Previous Month+98.50%Dollar Volume Sold Short$5.70 millionShort Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares671,070,000 sharesShort Percent of Float0.74%Today's Trading Volume300 sharesAverage Trading Volume500 sharesToday's Volume Vs. Average60% Short Selling Pharming Group? Sign up to receive the latest short interest report for Pharming Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHGUF Short Interest Over TimePHGUF Days to Cover Over TimePHGUF Percentage of Float Shorted Over Time Pharming Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20254,952,300 shares $5.70 million +98.5%0.7%0 $1.15 7/15/20252,494,900 shares $2.87 million +0.3%N/A0 $1.15 6/30/20252,487,900 shares $2.86 million -1.0%0.4%24879 $1.15 6/15/20252,512,300 shares $2.98 million 0.0%0.4%12561.5 $1.19 5/31/20252,512,800 shares $2.51 million -6.3%0.4%12564 $1.00 5/15/20252,682,000 shares $2.45 million -10.3%0.4%0 $0.91 4/30/20252,988,300 shares $2.73 million -4.5%N/A14941.5 $0.91 4/15/20253,130,400 shares $2.82 million -6.3%0.5%0 $0.90 3/31/20253,342,300 shares $3.01 million -30.8%0.5%0 $0.90 3/15/20254,828,600 shares $4.35 million -6.1%0.7%139.6 $0.90 Get the Latest News and Ratings for PHGUF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 2/28/20255,143,300 shares $4.76 million +3.8%0.8%6429.1 $0.93 2/15/20254,955,800 shares $4.34 million -11.2%0.7%12389.5 $0.88 1/31/20255,579,000 shares $5.22 million -10.1%N/A27895 $0.94 1/15/20256,204,700 shares $5.77 million -7.1%N/A8863.9 $0.93 12/31/20246,677,100 shares $6.55 million -4.2%N/A3035 $0.98 12/15/20246,969,800 shares $5.32 million -3.1%N/A13939.6 $0.76 11/30/20247,193,500 shares $5.36 million +12.1%N/A14387 $0.75 11/15/20246,416,300 shares $5.28 million +0.0%N/A0 $0.82 10/31/20246,415,900 shares $5.28 million -10.6%N/A64159 $0.82 10/15/20247,179,000 shares $6.15 million +4.4%N/A35895 $0.86 9/30/20246,876,400 shares $5.19 million +10.2%N/A13752.8 $0.75 9/15/20246,238,700 shares $4.71 million +3.8%N/A31193.5 $0.75 8/31/20246,009,600 shares $4.96 million +1.7%N/A0 $0.82 8/15/20245,907,800 shares $4.87 million -5.7%N/A1342.7 $0.82 7/31/20246,262,200 shares $4.70 million +0.5%N/A1332.4 $0.75 7/15/20246,228,300 shares $5.29 million +5.8%N/A31141.5 $0.85 6/30/20245,887,400 shares $4.74 million +0.4%N/A29437 $0.81 6/15/20245,861,900 shares $5.44 million +6.6%N/A29309.6 $0.93 5/31/20245,500,400 shares $5.11 million -5.7%N/A11000.8 $0.93 5/15/20245,830,500 shares $5.56 million +23.7%N/A0 $0.95 4/30/20244,713,600 shares $4.50 million +137.3%N/A15712 $0.95 4/15/20241,986,400 shares $2.12 million -8.2%N/A4966 $1.07 3/31/20242,163,800 shares $2.60 million +4.4%N/A0 $1.20 3/15/20242,072,400 shares $2.49 million -4.8%N/A767.6 $1.20 2/29/20242,177,000 shares $2.55 million +2.7%N/A21770 $1.17 2/15/20242,120,700 shares $2.48 million -8.7%N/A5301.8 $1.17 1/15/20243,254,500 shares $3.82 million -50.8%N/A0 $1.18 12/31/20236,614,000 shares $7.77 million -15.1%N/A0 $1.18 12/15/20237,786,400 shares $9.15 million -0.6%N/A9733 $1.18 11/30/20237,831,200 shares $8.93 million +17.2%N/A78312 $1.14Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 11/15/20236,680,500 shares $7.62 million -8.0%N/A0 $1.14 10/31/20237,262,800 shares $8.28 million -6.8%N/A0 $1.14 10/15/20237,788,600 shares $8.88 million -5.7%N/A217.6 $1.14 9/30/20238,261,900 shares $10.74 million -6.9%N/A82619 $1.30 9/15/20238,875,400 shares $10.92 million -0.3%N/A4930.8 $1.23 8/31/20238,902,400 shares $11.04 million +7.8%N/A0 $1.24 8/15/20238,257,600 shares $10.24 million -0.7%N/A0 $1.24 7/31/20238,317,200 shares $10.31 million -4.0%N/A20793 $1.24 7/15/20238,662,600 shares $10.74 million -4.0%N/A2406.3 $1.24 6/30/20239,018,400 shares $10.60 million +2.1%N/A90184 $1.18 6/15/20238,833,300 shares $10.86 million +12.3%N/A2103.2 $1.23 5/31/20237,867,900 shares $9.44 million +5.8%N/A26226.3 $1.20 5/15/20237,437,900 shares $8.70 million +15.2%N/A74379 $1.17 4/30/20236,456,400 shares $7.04 million +38.0%N/A64564 $1.09 4/15/20234,679,100 shares $5.43 million +22.8%N/A3899.3 $1.16 3/31/20233,809,300 shares $4.80 million +17.9%N/A1029.5 $1.26 3/15/20233,231,000 shares $3.72 million +19.2%N/A4038.8 $1.15 2/28/20232,709,800 shares $3.07 million -16.4%N/A6774.5 $1.13 2/15/20233,240,100 shares $4.37 million -27.9%N/A3240.1 $1.35 1/31/20234,490,500 shares $6.42 million +1.2%N/A2041.1 $1.43 1/15/20234,437,200 shares $5.64 million +0.5%N/A11093 $1.27 12/30/20224,416,300 shares $5.08 million -0.5%N/A1577.3 $1.15 12/15/20224,436,400 shares $5.23 million +0.0%N/A2334.9 $1.18 11/30/20224,435,700 shares $5.37 million -6.7%N/A44357 $1.21 11/15/20224,756,400 shares $5.23 million +5.3%N/A15854.7 $1.10 10/31/20224,515,900 shares $4.43 million -4.9%N/A45159 $0.98 10/15/20224,748,300 shares $4.91 million -8.1%N/A47483 $1.04 9/30/20225,164,800 shares $5.55 million +23.2%N/A2582.4 $1.08 9/15/20224,191,000 shares $4.86 million +0.7%N/A530.5 $1.16 8/31/20224,162,700 shares $4.87 million -1.4%N/A1892.1 $1.17 8/15/20224,222,800 shares $4.14 million +250.6%N/A391 $0.98 7/31/20221,204,500 shares $955.17 thousand +3.4%N/A0 $0.79 7/15/20221,164,400 shares $923.37 thousand -9.0%N/A0 $0.79 6/30/20221,279,100 shares $1.01 million -46.4%N/A1279.1 $0.79 6/15/20222,387,900 shares $1.84 million +6.4%N/A723.6 $0.77 5/31/20222,244,600 shares $1.90 million +66.6%N/A273.7 $0.85 5/15/20221,347,300 shares $1.04 million -11.7%N/A748.5 $0.77 4/30/20221,525,800 shares $1.23 million +31.7%N/A3814.5 $0.81 4/15/20221,158,400 shares $1.10 million -23.5%N/A2896 $0.95 3/31/20221,513,600 shares $1.35 million +230.6%N/A7568 $0.89 3/15/2022457,800 shares $366.70 thousand -48.0%N/A57.2 $0.80 2/28/2022881,100 shares $786.47 thousand -3.8%N/A1762.2 $0.89 2/15/2022915,400 shares $823.86 thousand -57.5%N/A0 $0.90 1/31/20222,152,400 shares $1.94 million -13.1%N/A10762 $0.90 1/15/20222,477,900 shares $2.35 million -17.3%N/A1548.7 $0.95 12/31/20212,995,100 shares $2.61 million +2.3%N/A809.5 $0.87 12/15/20212,929,000 shares $2.25 million -22.3%N/A3254.4 $0.77 11/30/20213,768,500 shares $2.86 million +24.6%N/A418.7 $0.76 11/15/20213,025,800 shares $2.72 million -18.0%N/A248 $0.90 10/29/20213,692,000 shares $3.44 million -0.5%N/A450.2 $0.93Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 10/15/20213,711,400 shares $3.34 million +12.8%N/A353.5 $0.90 9/30/20213,291,600 shares $3.00 million -23.5%N/A313.5 $0.91 9/15/20214,300,000 shares $4.20 million -15.8%N/A8600 $0.98 8/31/20215,106,200 shares $5.16 million -18.7%N/A51062 $1.01 8/13/20216,276,900 shares $6.34 million -48.2%N/A294.7 $1.01 7/30/202112,110,700 shares $13.93 million -0.5%N/A608.6 $1.15 7/15/202112,166,700 shares $14.11 million -37.2%N/A3041.7 $1.16 6/30/202119,367,700 shares $21.30 million +11.0%N/A14898.2 $1.10 6/15/202117,453,900 shares $20.94 million -1.8%N/A19393.2 $1.20 5/28/202117,781,600 shares $21.69 million -10.1%N/A13678.2 $1.22 5/14/202119,776,500 shares $23.83 million +2.2%N/A5345 $1.21 4/30/202119,346,100 shares $25.15 million -1.5%N/A193461 $1.30 4/15/202119,632,700 shares $25.72 million -0.5%N/A32721.2 $1.31 3/31/202119,730,900 shares $25.24 million +0.1%N/A39461.8 $1.28 3/15/202119,702,500 shares $26.40 million -6.6%N/A7577.9 $1.34 2/26/202121,094,800 shares $28.69 million +4.0%N/A8437.9 $1.36 2/12/202120,282,600 shares $28.19 million -1.3%N/A1090.5 $1.39 1/29/202120,553,700 shares $29.45 million -2.6%N/A2476.3 $1.43 1/15/202120,341,100 shares $29.70 million -1.2%N/A2285.5 $1.46 12/31/202021,137,300 shares $33.19 million +3.9%N/A334.5 $1.57 12/15/202020,341,100 shares $28.58 million -1.2%N/A2285.5 $1.41 11/30/202020,596,500 shares $28.42 million +0.6%N/A3269.3 $1.38 11/15/202020,479,100 shares $26.11 million -2.4%N/A2467.4 $1.28 10/30/202020,972,500 shares $22.44 million -4.9%N/A69908.3 $1.07 10/15/202022,042,400 shares $25.13 million -4.6%N/A2204.2 $1.14 9/30/202023,115,500 shares $26.00 million -2.9%N/A2222.6 $1.13 9/15/202023,799,200 shares $29.27 million -2.1%N/A4175.3 $1.23 8/31/202024,297,100 shares $30.13 million +0.3%N/A17355.1 $1.24 PHGUF Short Interest - Frequently Asked Questions What is Pharming Group's current short interest? Short interest is the volume of Pharming Group shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 4,952,300 shares of PHGUF short. 0.74% of Pharming Group's shares are currently sold short. Learn More on Pharming Group's current short interest. What is a good short interest percentage for Pharming Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.74% of Pharming Group's floating shares are currently sold short. Is Pharming Group's short interest increasing or decreasing? Pharming Group saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 4,952,300 shares, an increase of 98.5% from the previous total of 2,494,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharming Group's short interest compare to its competitors? 0.74% of Pharming Group's shares are currently sold short. Here is how the short interest of companies in the industry of "med - biomed/gene" compare to Pharming Group: Kymera Therapeutics, Inc. (14.17%), Scholar Rock Holding Corporation (17.84%), Ligand Pharmaceuticals Incorporated (5.10%), Xenon Pharmaceuticals Inc. (9.47%), Bavarian Nordic (0.00%), HUTCHMED (China) Limited Sponsored ADR (0.23%), Ultragenyx Pharmaceutical Inc. (8.39%), Arrowhead Pharmaceuticals, Inc. (9.78%), Immunovant, Inc. (23.94%), Kiniksa Pharmaceuticals International, plc (7.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Pharming Group stock? Short selling PHGUF is an investing strategy that aims to generate trading profit from Pharming Group as its price is falling. PHGUF shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharming Group? A short squeeze for Pharming Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHGUF, which in turn drives the price of the stock up even further. How often is Pharming Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHGUF, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies KYMR Short Interest Data SRRK Short Interest Data LGND Short Interest Data XENE Short Interest Data BVNRY Short Interest Data HCM Short Interest Data RARE Short Interest Data ARWR Short Interest Data IMVT Short Interest Data KNSA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PHGUF) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access